Medical Injury Lawyer Blog : Houston Medical Injury Lawyer & Attorney : Arnold & Itkin Law Firm : Pharmaceutical Injuries, Medical Devices : Texas, Dallas, Fort Worth, San Antonio

Watson Pharmaceuticals Inc. announced that it is recalling one lot of Propafenone HCL 225 mg tablets because they may contain a more intense dose of the active ingredient than is needed. The recall affects a single lot of the tablets that was shipped between October 15th and November 26th of 2008.

Propafenone is used in the treatment of cardiac arrhythmias, including conditions associated with accelerated heartbeat, like ventricular and atrial arrhythmias. However, it can be dangerous if not used as prescribed. The drug is believed to increase the risk of dangerous arrhythmias if taken by patients who have an underlying heart disease. Patients who suffer from liver problems, asthma, or bradycardia are also advised to avoid Propafenone. The long term effects of the drug have not been extensively researched. Even minor over-dosage of Propafenone has been found to have serious effects. Patients who take even small quantities of the drug above the prescribed limit could experience a drop in blood pressure and arrhythmias.

Watson Pharmaceuticals Inc. says they are voluntarily recalling the lot of tablets to prevent any risk to patients due to over dosage. The Food and Drug Administration (FDA) has been informed of the recall and the company has asked patients who are in possession of the 225 mg tablets to check the container and see if the tablets belong to the lot being recalled. Consumers should return the recalled tablets by calling the company. Any adverse reactions should be reported to the FDA’s MedWatch program. Patients currently using 225 mg Propafenone HCL tablets have been asked to contact their physician if they have any questions.

Last year, Ethex Corporation announced a recall of over sized morphine Sulphate, Propafenone HCI, and other tablets because they contained twice the necessary amount of the drug. Those over sized tablets caused morphine over dosage injuries and resulted in several medical injury lawsuits filed by medical injury lawyers against Ethex. Also, medical injury lawsuits continue to be filed against Mylan Pharmaceuticals over double strength Digitek tablets that contain extra dosages of the active ingredient Digoxin. 

Injuries Caused by Defective Drugs

Over dosage due to a defective pharmaceutical drug containing a greater amount of the active ingredient than is necessary is entirety preventable by the company if it follows stringent manufacturing and quality control processes. There is no excuse for releasing batches of drugs that expose users to dangerous effects of over dosage because of careless errors made at the manufacturing plant.  

If you've been inured by the use of recalled Propafenone HCL tablets manufactured by Watson Pharmaceuticals Inc., contact a medical injury lawyer at Arnold & Itkin LLP for a free consultation.

• Print
• Trackbacks
• Share Link

Ethex Corp and FDA notified healthcare professionals of a voluntary recall of five generic products:

• Propafenone HCl Tablets
• Isosorbide Mononitrate Extended Release Tablets
• Morphine Sulfate Extended Release Tablets
• Morphine Sulfate Immediate Release Tablets
• Dextroamphetamine Sulfate Tablets

The products were recalled because they may contain oversized tablets. Oversized tablets may contain more than the intended levels of the active drug ingredient that could result in patients receiving as much as twice the expected dosage of these drugs, which could cause serious or life-threatening consequences.

Overdoses can include arrhythmias and low blood pressure with Propafenone HCl; fainting and low blood pressure with Isosorbide Mononitrate; respiratory depression and low blood pressure with Morphine Sulfate; and rapid heart rate and high blood pressure with Dextroamphetamine Sulfate. Patients who experience any adverse reactions to these drugs should contact their healthcare professional immediately. See the manufacturer's drug recall notice for specific lot numbers of the products affected by this recall.

The side effects associated with these dangerous drugs are serious and life threatening. Consumers who experience any adverse reactions to these drugs should contact their physician and/or healthcare provider immediately. If you are a loved one have been serious injured by one of these defective pharmaceutical drugs, you should contact a medical injury lawyer to learn more about your options for claiming compensation you may be due.

• Print
• Comments
• Trackbacks
• Share Link

Covidien has recalled ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed hypodermic needles. The mislabeled syringe may result in patients receiving an overdose of as much as 2.5 times the intended dose, with serious health consequences, low blood sugar, and even death.

These syringes are sold only by Wal-Mart or Sam's Club pharmacies under the ReliOn name. The recall applies only to lot number 813900. The product was distributed from Aug. 1, 2008 until Oct. 8, 2008, and includes 471,000 individual syringes in 4,710 boxes.

FDA urges patients and health care professionals to check syringe packaging carefully for products with this lot number, not to use the product, and return the product to the pharmacy for replacement. The lot number can be found on the back panel of the 100 count syringe carton, or on the white paper backing of each individual syringe “peel-pack”.

If you or a loved one has been injured by this defective pharmaceutical product, you may be entitled to compensation. A medical injury lawyer can help you hold them accountable.  Contact a medical injury lawyer at Arnold & Itkin LLP. We can answer questions and help you understand your options.

• Print
• Comments
• Trackbacks
• Share Link